ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 12 filers reported holding ENLIVEX THERAPEUTICS LTD in Q4 2020. The put-call ratio across all filers is 3.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,740 | -39.9% | 3,000 | 0.0% | 0.00% | – |
| Q2 2023 | $7,882 | -27.8% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $10,920 | -7.6% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $11,813 | -9.1% | 3,000 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -7.1% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -17.6% | 3,000 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2021 | $17,000 | -89.1% | 3,000 | -80.6% | 0.00% | -100.0% |
| Q3 2021 | $156,000 | +14.7% | 15,500 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $136,000 | -100.0% | 15,500 | -50.0% | 0.00% | -33.3% |
| Q1 2021 | $330,758,000 | +4134375.0% | 31,000 | +1966.7% | 0.00% | – |
| Q3 2020 | $8,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |